SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (13101)1/8/1998 8:32:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Andy, Here's the post from the cancer board. Doesn't say how patient is doing, but Melanoma is not listed on the cheat sheet for Targretin:

Doyle,

My husband Sy has courageously battled cancer for over a decade. He has
had ocular melanoma for 2 yrs and has had enucleation surgery at
Wills/Philadelphia in JAN 1996, and isolated liver perfusion operation
for the mets, at NIH/Bethesda in FEB 1997. He has survived this long
and is still battling the disease. This week, he just started on a brand
new drug protocol, Targretin, for Stage IV melanoma patients at M.D.
Anderson/Houston. The wonderful doctors there think he is a walking
miracle because the initial prognosis for this disease, with mets to
liver, is @ 6 months liver. Over the past 10 years, he has also done
battle with TCC of the bladder, and had it successfully treated by a
wonderful urologist at Johns Hopkins.

I will share with you how he has kept up his survival, enjoying each day
as it comes, and buying time hopefully,until there is a cure:
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext